These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29484273)

  • 1. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.
    Le Masson G; Solé G; Desnuelle C; Delmont E; Gauthier-Darnis M; Puget S; Durand-Zaleski I
    Brain Behav; 2018 Feb; 8(2):e00923. PubMed ID: 29484273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic costs and quality of life in chronic inflammatory neuropathies in southeast England.
    Mahdi-Rogers M; McCrone P; Hughes RA
    Eur J Neurol; 2014; 21(1):34-9. PubMed ID: 23930744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
    Perraudin C; Bourdin A; Vicino A; Kuntzer T; Bugnon O; Berger J
    PLoS One; 2020; 15(11):e0242630. PubMed ID: 33237959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies.
    Beauté J; Levy P; Millet V; Debré M; Dudoit Y; Le Mignot L; Tajahmady A; Thomas C; Suarez F; Pellier I; Hermine O; Aladjidi N; Mahlaoui N; Fischer A;
    Clin Exp Immunol; 2010 May; 160(2):240-5. PubMed ID: 20041884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
    Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.
    McCrone P; Chisholm D; Knapp M; Hughes R; Comi G; Dalakas MC; Illa I; Kilindireas C; Nobile-Orazio E; Swan A; Van den Bergh P; Willison HJ;
    Eur J Neurol; 2003 Nov; 10(6):687-94. PubMed ID: 14641514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home IVIG for CIDP: a focus on patient centred care.
    Katzberg HD; Rasutis V; Bril V
    Can J Neurol Sci; 2013 May; 40(3):384-8. PubMed ID: 23603176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?
    Rosier C; Graveline N; Lacour A; Antoine JC; Camdessanché JP
    Eur J Neurol; 2019 Apr; 26(4):575-580. PubMed ID: 30326184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.
    Lucke IM; Adrichem ME; Wieske L; van der Kooi AJ; Verhamme C; van Schaik IN; Eftimov F
    J Neurol Sci; 2019 Feb; 397():141-145. PubMed ID: 30623818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies.
    Gallia F; Balducci C; Nobile-Orazio E
    J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Immune-Mediated Polyneuropathies.
    Cox SZ; Gwathmey KG
    Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases.
    Sala TP; Crave JC; Duracinsky M; Lepira Bompeka F; Tadmouri A; Chassany O; Cherin P
    Autoimmun Rev; 2018 Sep; 17(9):873-881. PubMed ID: 30005853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.